Aotearoa Immunisation Register (AIR) FHIR Implementation Guide
2.7.0 - ci-build
New Zealand
Aotearoa Immunisation Register (AIR) FHIR Implementation Guide - Local Development build (v2.7.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
| Official URL: https://nzhts.digital.health.nz/fhir/ValueSet/air-vaccine-product-map | Version: 2.7.0 | |||
| Draft as of 2026-07-20 | Computable Name: AIRAdministeredProduct-Vaccine-Map | |||
This map connects vaccine products as identified by the Therapeutic Product Unit of Use (TPUU) code in the New Zealand Medicines Terminology (NZMT) to the vaccines as identified by CVX codes. This mapping facilitates translating TPUU codes stored in ImmSOT to a CVX code that can be received by legacy PMS systems.
Mapping from AIR Administered Product Code to AIR Vaccine Product
Group 1 Mapping from http://nzmt.org.nz to Vaccine Administered Code Set (CVX)
| Source Code | Relationship | Target Code |
| 10443641000116108 | is related to | 03 (measles, mumps and rubella virus vaccine) |
| 44016911000116108 | is related to | 03 (measles, mumps and rubella virus vaccine) |
| 10319251000116109 | is related to | 48 (Haemophilus influenzae type b vaccine, PRP-T conjugate) |
| 10695781000116100 | is related to | 21 (varicella virus vaccine) |
| 46101011000116102 | is related to | 165 (Human Papillomavirus 9-valent vaccine) |
| 29448821000116105 (Zostavax (Varicella zoster virus (Oka strain) live attenuated vaccine 19 400 PFU) injection: powder for, vial) | is related to | 121 (zoster vaccine, live) |
| 46770131000116100 (Shingrix (Varicella zoster virus recombinant glycoprotein E antigen vaccine 50 microgram) injection: powder for, vial) | is related to | 121 (zoster vaccine, live) |
| 47407751000116105 (Comirnaty (Pfizer-BioNTech) (tozinameran (BNT162b2) (mRNA) 225 microgram/0.45 mL (30 microgram/0.3 mL administered dose)) (purple) COVID-19 mRNA vaccine injection: concentrated, vial [obsolete]) | is related to | 208 (SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose) |
| 47547081000116102 (Comirnaty (Pfizer-BioNTech) (tozinameran (BNT162b2) (mRNA) 130 microgram/1.3 mL (10 microgram/0.2 mL administered dose)) (orange) COVID-19 mRNA vaccine injection: concentrated, vial [Obsolete]) | is related to | 218 (SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 10 mcg/0.2mL dose, tris-sucrose formulation) |
| 47572291000116106 (Comirnaty (Pfizer-BioNTech) (tozinameran (BNT162b2) (mRNA) 225 microgram/2.25 mL (30 microgram/0.3 mL administered dose)) (grey) COVID-19 mRNA vaccine injection: suspension, vial [Obsolete]) | is related to | 217 (SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose, tris-sucrose formulation) |
| 46580601000116106 (Bexsero (syringe without needle) (Neisseria meningitidis group B NHBA fusion protein 50 microgram/0.5 mL + Neisseria meningitidis group B NadA protein 50 microgram/0.5 mL + Neisseria meningitidis group B fHbp fusion protein 50 microgram/0.5 mL + Neisseria meningitidis serogroup B outer membrane vesicles 25 microgram/0.5 mL) injection: suspension, syringe) | is related to | 163 (meningococcal B vaccine, recombinant, OMV, adjuvanted) |
| 46580461000116107 (Bexsero (syringe with needle) (Neisseria meningitidis group B NHBA fusion protein 50 microgram/0.5 mL + Neisseria meningitidis group B NadA protein 50 microgram/0.5 mL + Neisseria meningitidis group B fHbp fusion protein 50 microgram/0.5 mL + Neisseria meningitidis serogroup B outer membrane vesicles 25 microgram/0.5 mL) injection: suspension, syringe) | is related to | 163 (meningococcal B vaccine, recombinant, OMV, adjuvanted) |
| 47768031000116109 (Jynneos (vaccinia virus (modified strain Ankara-Bavarian Nordic (non replicating)) vaccine 50 million infectious units/0.5 mL) injection: suspension, vial) | is related to | 75 (Vaccinia (smallpox, mpox) vaccine, live) |
| 46044951000116103 (Pneumovax 23 Vaccine (pneumococcal (Streptococcus pneumoniae) polysaccharide (serotype 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, 33F) vaccine 575 microgram/0.5 mL) injection: solution, syringe) | is related to | 33 (pneumococcal polysaccharide vaccine, 23 valent) |
| 20077561000116105 (Prevenar 13 Vaccine (pneumococcal (Streptococcus pneumoniae) polysaccharide conjugate (serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 23F) vaccine 30.8 microgram/0.5 mL) injection: suspension, syringe) | is related to | 133 (pneumococcal conjugate vaccine, 13 valent) |
| 10380351000116108 (Ipol (poliovirus inactivated antigens (type 1 (Mahoney) 40 D antigen units/0.5 mL + type 2 (MEF-1) 8 D antigen units/0.5 mL + type 3 (Saukett) 32 D antigen units) vaccine) injection: suspension, syringe [Obsolete]) | is related to | 10 (poliovirus vaccine, inactivated) |
| 47666491000116106 (BCG Vaccine AJV (Bacillus Calmette-Guerin Danish 1331 strain live attenuated vaccine 750 microgram) injection: powder for, vial) | is related to | 19 (Bacillus Calmette-Guerin vaccine) |
| 10336221000116104 (Havrix (hepatitis A virus inactivated 1440 ELISA units/mL) vaccine injection: suspension, syringe) | is related to | 52 (hepatitis A vaccine, adult dosage) |
| 31171221000116106 (Engerix-B Adult (hepatitis B virus surface antigen vaccine 20 microgram/mL) injection: suspension, syringe) | is related to | 43 (hepatitis B vaccine, adult dosage) |
| 47562481000116104 (MenQuadfi (meningococcal group A (Neisseria meningitidis) polysaccharide 10 microgram/0.5 mL + meningococcal group C (Neisseria meningitidis) polysaccharide 10 microgram/0.5 mL + meningococcal group W (Neisseria meningitidis) polysaccharide 10 microgram/0.5 mL + meningococcal group Y (Neisseria meningitidis) polysaccharide 10 microgram/0.5 mL) conjugate vaccine injection: solution, vial) | is related to | 114 (meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4P)) |
| 46083691000116109 (Engerix-B Paediatric (hepatitis B virus surface antigen vaccine 10 microgram/0.5 mL) injection: suspension, vial) | is related to | 08 (hepatitis B vaccine, pediatric or pediatric/adolescent dosage) |
| 43964841000116102 (Havrix Junior (hepatitis A virus inactivated 720 ELISA units/0.5 mL) vaccine injection: suspension, vial) | is related to | 83 (hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule) |
| 10695851000116103 (Varivax (Varicella zoster virus (Oka strain) live attenuated vaccine 1350 PFU) injection: powder for, vial) | is related to | 21 (varicella virus vaccine) |
| 44630041000116108 (Nimenrix (meningococcal group A (Neisseria meningitidis) polysaccharide 5 microgram + meningococcal group C (Neisseria meningitidis) polysaccharide 5 microgram + meningococcal group W135 (Neisseria meningitidis) polysaccharide 5 microgram + meningococcal group Y (Neisseria meningitidis) polysaccharide 5 microgram) conjugate vaccine injection: powder for, vial) | is related to | 114 (meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4P)) |
| 47959701000116108 (Rotarix (rotavirus G1P(8) RIX4414 strain live attenuated oral vaccine 1 million CCID50 units/1.5 mL) oral liquid: suspension, tube) | is related to | 119 (rotavirus, live, monovalent vaccine) |
| 44006761000116105 (Twinrix (hepatitis A virus inactivated 720 ELISA units/mL + hepatitis B virus surface antigen recombinant 20 microgram/mL) vaccine injection: suspension, 1 mL vial) | is related to | 104 (hepatitis A and hepatitis B vaccine) |
| 44007131000116104 (Twinrix Junior (hepatitis A virus inactivated 360 ELISA units/0.5 mL + hepatitis B virus surface antigen recombinant 10 microgram/0.5 mL) vaccine injection: suspension, 0.5 mL vial) | is related to | 104 (hepatitis A and hepatitis B vaccine) |
| 10693001000116105 (Typhim Vi (typhoid Vi polysaccharide 25 microgram/0.5 mL) vaccine injection: solution, syringe) | is related to | 101 (typhoid Vi capsular polysaccharide vaccine) |
| 29557441000116106 (Vivotif Oral (typhoid Ty21a live attenuated 2000 million organisms) vaccine capsule: modified release, 1 capsule) | is related to | 25 (typhoid vaccine, live, oral) |
| 10645561000116106 (Stamaril (Yellow fever (17D) live attenuated vaccine 1000 international units) injection: powder for, vial) | is related to | 37 (yellow fever vaccine live) |
| 29430601000116101 (Jespect (Japanese encephalitis virus inactivated vaccine 6 microgram/0.5 mL) injection: suspension, syringe) | is related to | 134 (Japanese Encephalitis vaccine for intramuscular administration) |
| 10215541000116100 (Dukoral Oral Suspension (cholera (toxin B subunit recombinant) 1 mg + cholera (Vibrio cholerae) inactivated strains (O1 Inaba classic 25 billion vibrios + O1 Inaba El Tor 25 billion vibrios + O1 Ogawa classic 50 billion vibrios)) vaccine oral liquid: suspension, 3 mL vial [Obsolete]) | is related to | 26 (cholera vaccine, unspecified formulation) |
| 44741471000116105 (TicoVac (tick-borne encephalitis virus inactivated vaccine 2.4 microgram) injection, 0.5 mL syringe) | is related to | 222 (Tick-borne encephalitis vaccine, unspecified) |
| 44881101000116100 (Hyperhep B (hepatitis B virus immunoglobulin, human 110 international units/0.5 mL) injection: solution, syringe) | is related to | 30 (hepatitis B immune globulin) |
| 29458231000116105 (Menactra (meningococcal group A (Neisseria meningitidis) polysaccharide 4 microgram + meningococcal group C (Neisseria meningitidis) polysaccharide 4 microgram + meningococcal group W135 (Neisseria meningitidis) polysaccharide 4 microgram + meningococcal group Y (Neisseria meningitidis) polysaccharide 4 microgram) conjugate vaccine injection: solution, 0.5 mL vial) | is related to | 114 (meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4P)) |
| 47757241000116104 (Comirnaty (Pfizer-BioNTech) (tozinameran (BNT162b2) (mRNA) 40 microgram/0.4 mL (3 microgram/0.2 mL administered dose)) (maroon) COVID-19 mRNA vaccine injection: concentrated, vial [Obsolete]) | is related to | 219 (SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 3 mcg/0.2mL dose, tris-sucrose formulation) |
| 47812711000116103 (Comirnaty Original/Omicron BA.4-5 (tozinameran (BNT162b2) 112.5 microgram/2.25 mL + famtozinameran 112.5 microgram/2.25 mL) (30 microgram/0.3 mL administered dose) (grey) COVID-19 mRNA vaccine injection: suspension, vial [Obsolete]) | is related to | 300 (SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 30 mcg/0.3 mL dose, tris-sucrose formulation) |
| 47411141000116100 (Nuvaxovid with Matrix-M Adjuvant (NVX-CoV2373) (Novavax) (SARS-CoV-2 rS (recombinant spike protein) (NVX-CoV2373) nanoparticle 5 microgram/0.5 mL) COVID-19 adjuvanted nanoparticle vaccine injection: suspension, vial) | is related to | 211 (SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 0.5mL dose) |
| 47362071000116105 (Vaxzevria (COVID-19 Vaccine AstraZeneca) (ChAdOx1-S virus 50 billion viral particles/0.5 mL) COVID-19 vaccine, injection: solution, vial) | is related to | 210 (SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-ChAdOx1, preservative free, 0.5 mL) |
| 10085391000116108 (Avaxim (hepatitis A virus inactivated vaccine 160 antigen units/0.5 mL) injection: suspension, syringe) | is related to | 52 (hepatitis A vaccine, adult dosage) |
| 44269461000116103 (Panvax H1N1 Vaccine 2009 (A/California/7/2009 (H1N1) (NYMC X-179A) (A/California/7/2009 (H1N1)v-like) inactivated vaccine 15 microgram/0.5 mL) injection: suspension, syringe) | is related to | 127 (Novel influenza-H1N1-09, injectable) |
| 44967911000116100 (Panvax Vaccine (influenza virus type A pandemic haemagglutinin vaccine 30 microgram/0.5 mL) injection: suspension, vial) | is related to | 160 (Influenza A monovalent (H5N1), adjuvanted, National stockpile 2013) |
| 48111641000116101 (Arexvy Respiratory Syncytial Virus Vaccine (respiratory syncytial virus pre-fusion F protein recombinant vaccine 120 microgram/0.5 mL) injection: powder for, vial) | is related to | 303 (Respiratory syncytial virus (RSV), vaccine, recombinant, protein subunit RSV prefusion F, adjuvant reconstituted, 0.5 mL, preservative free) |
| 48175861000116107 (Comirnaty Omicron XBB.1.5 (raxtozinameran 48 microgram/0.48 mL) (30 microgram/0.3 mL administered dose) (light grey SDV) COVID-19 mRNA vaccine injection: suspension, vial [obsolete]) | is related to | 217 (SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose, tris-sucrose formulation) |
| 48175171000116106 (Comirnaty Omicron XBB.1.5 (raxtozinameran 225 microgram/2.25 mL) (30 microgram/0.3 mL administered dose) (dark grey MDV) COVID-19 mRNA vaccine injection: suspension, vial [obsolete]) | is related to | 217 (SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose, tris-sucrose formulation) |
| 48176671000116109 (Comirnaty Omicron XBB.1.5 (raxtozinameran 16 microgram/0.48 mL) (10 microgram/0.3 mL administered dose) (light blue SDV) COVID-19 mRNA vaccine injection: suspension, vial [obsolete]) | is related to | 218 (SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 10 mcg/0.2mL dose, tris-sucrose formulation) |
| 48179211000116107 (Comirnaty Omicron XBB.1.5 (raxtozinameran 15.8 microgram/0.48 mL) (3 microgram/0.3 mL administered dose) (yellow MDV) COVID-19 mRNA vaccine injection: concentrated, vial [obsolete]) | is related to | 219 (SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 3 mcg/0.2mL dose, tris-sucrose formulation) |
| 31115901000116100 (Act-HIB (Haemophilus influenzae type b polysaccharide conjugate 10 microgram) vaccine injection: powder for, vial) | is related to | 48 (Haemophilus influenzae type b vaccine, PRP-T conjugate) |
Group 2 Mapping from http://nzmt.org.nz to NZVX Immunisation Code
| Source Code | Relationship | Target Code |
| 44305771000116109 (Rabipur (rabies virus inactivated vaccine 2.5 international units) injection: powder for, vial) | is related to | 99009 (Rabies) |
| 10417931000116105 (Merieux Inactivated Rabies Vaccine (rabies virus inactivated vaccine 2.5 international units) injection: suspension, vial) | is related to | 99009 (Rabies) |
| 31128931000116109 (NeisVac-C (meningococcal group C (strain C11) (Neisseria meningitidis) polysaccharide 10 microgram/0.5 mL) conjugate vaccine injection: suspension, syringe) | is related to | 99013 (MenC) |
| 47972211000116109 (Afluria Quad 2023 (A/Sydney/5/2021 (H1N1) pdm09 - like virus 15 microgram/0.5 mL + A/Darwin/9/2021 (H3N2) - like virus 15 microgram/0.5 mL + B/Austria/1359417/2021 - like virus 15 microgram/0.5 mL + B/Phuket/3073/2013 - like virus 15 microgram/0.5 mL) influenza vaccine injection: suspension, syringe [Obsolete]) | is related to | 99006 (Influenza) |
| 47972411000116108 (Afluria Quad Junior 2023 (A/Sydney/5/2021 (H1N1) pdm09 - like virus 7.5 microgram/0.25 mL + A/Darwin/9/2021 (H3N2) - like virus 7.5 microgram/0.25 mL + B/Austria/1359417/2021 - like virus 7.5 microgram/0.25 mL + B/Phuket/3073/2013 - like virus 7.5 microgram/0.25 mL) influenza vaccine injection: suspension, syringe [Obsolete]) | is related to | 99006 (Influenza) |
| 47972611000116106 (Fluad Quad 2023 (A/Sydney/5/2021 (H1N1) pdm09 - like virus 15 microgram/0.5 mL + A/Darwin/9/2021 (H3N2) - like virus 15 microgram/0.5 mL + B/Austria/1359417/2021 - like virus 15 microgram/0.5 mL + B/Phuket/3073/2013 - like virus 15 microgram/0.5 mL) influenza vaccine injection: suspension, syringe [obsolete]) | is related to | 99006 (Influenza) |
| 47988151000116108 (FluQuadri 2023 (A/Sydney/5/2021 (H1N1) pdm09 - like virus 15 microgram/0.5 mL + A/Darwin/9/2021 (H3N2) - like virus 15 microgram/0.5 mL + B/Austria/1359417/2021 - like virus 15 microgram/0.5 mL + B/Phuket/3073/2013 - like virus 15 microgram/0.5 mL) influenza vaccine injection: suspension, syringe [Obsolete]) | is related to | 99006 (Influenza) |
| 47648581000116104 (Afluria Quad 2022 (A/Victoria/2570/2019 (H1N1) pdm09 - like virus 15 microgram/0.5 mL + A/Darwin/9/2021 (H3N2) - like virus 15 microgram/0.5 mL + B/Austria/1359417/2021 - like virus 15 microgram/0.5 mL + B/Phuket/3073/2013 - like virus 15 microgram/0.5 mL) influenza vaccine injection: suspension, syringe [Obsolete]) | is related to | 99006 (Influenza) |
| 47649511000116103 (Afluria Quad Junior 2022 (A/Victoria/2570/2019 (H1N1) pdm09 - like virus 7.5 microgram/0.25 mL + A/Darwin/9/2021 (H3N2) - like virus 7.5 microgram/0.25 mL + B/Austria/1359417/2021 - like virus 7.5 microgram/0.25 mL + B/Phuket/3073/2013 - like virus 7.5 microgram/0.25 mL) influenza vaccine injection: suspension, syringe [Obsolete]) | is related to | 99006 (Influenza) |
| 47648881000116102 (Fluad Quad 2022 (A/Victoria/2570/2019 (H1N1) pdm09 - like virus 15 microgram/0.5 mL + A/Darwin/9/2021 (H3N2) - like virus 15 microgram/0.5 mL + B/Austria/1359417/2021 - like virus 15 microgram/0.5 mL + B/Phuket/3073/2013 - like virus 15 microgram/0.5 mL) influenza vaccine injection: suspension, syringe [Obsolete]) | is related to | 99006 (Influenza) |
| 47664751000116102 (FluQuadri 2022 (A/Victoria/2570/2019 (H1N1) pdm09 - like virus 15 microgram/0.5 mL + A/Darwin/9/2021 (H3N2) - like virus 15 microgram/0.5 mL + B/Austria/1359417/2021 - like virus 15 microgram/0.5 mL + B/Phuket/3073/2013 - like virus 15 microgram/0.5 mL) influenza vaccine injection: suspension, syringe [Obsolete]) | is related to | 99006 (Influenza) |
| 10347971000116105 (Infanrix-IPV (diphtheria toxoid not less than 30 international units/0.5 mL + Bordetella pertussis acellular antigens (pertactin 8 microgram/0.5 mL + pertussis toxoid 25 microgram/0.5 mL + filamentous haemagglutinin 25 microgram/0.5 mL) + poliovirus inactivated antigen (type 1 (Mahoney) 40 D antigen units/0.5 mL + type 2 (MEF-1) 8 D antigen units/0.5 mL+ type 3 (Saukett) 32 D antigen units/0.5 mL) + tetanus toxoid not less than 40 international units/0.5 mL vaccine) injection: suspension, syringe) | is related to | 99001 (DTaP-IPV) |
| 10101121000116104 (Boostrix (diphtheria toxoid 2 international units + tetanus toxoid 20 international units + Bordetella pertussis acellular antigens (pertactin 2.5 microgram + pertussis toxoid 8 microgram + filamentous haemagglutinin 8 microgram) vaccine) injection: suspension, 0.5 mL syringe) | is related to | 99012 (Tdap) |
| 29455501000116107 (Infanrix-hexa (diphtheria toxoid not less than 30 international units/0.5 mL + hepatitis B virus surface antigen recombinant 10 microgram/0.5 mL + Bordetella pertussis acellular antigens (pertactin 8 microgram/0.5 mL + pertussis toxoid 25 microgram/0.5 mL + filamentous haemagglutinin 25 microgram/0.5 mL) + poliovirus inactivated antigen (type 1 (Mahoney) 40 D antigen units/0.5 mL + type 2 (MEF-1) 8 D antigen units/0.5 mL + type 3 (Saukett) 32 D antigen units) + tetanus toxoid not less than 40 international units/0.5 mL vaccine) injection: suspension, syringe) | is related to | 210307 (DTaP-IPV-HepB/Hib) |
| 10017131000116103 (Adacel (diphtheria toxoid 2 international units/ 0.5 mL + tetanus toxoid 20 international units/0.5 mL + Bordetella pertussis acellular antigens (pertactin 3 microgram/0.5 mL + pertussis toxoid 2.5 microgram/0.5 mL + filamentous haemagglutinin 5 microgram/0.5 mL + fimbriae (types 2 and 3) 5 microgram/0.5 mL)) vaccine injection: suspension, vial [obsolete]) | is related to | 99012 (Tdap) |
| 10017251000116104 (Adacel Polio (diphtheria toxoid 2 international units/0.5 mL + Bordetella pertussis acellular antigens (pertactin 3 microgram/0.5 mL + pertussis toxoid 2.5 microgram/0.5 mL + filamentous haemagglutinin 5 microgram/0.5 mL + fimbriae types 2 and 3 5 microgram/0.5 mL) + poliovirus inactivated antigen (type 1 (Mahoney) 40 D antigen units/0.5 mL + type 2 (MEF-1) 8 D antigen units/0.5 mL + type 3 (Saukett) 32 D antigen units/0.5 mL) + tetanus toxoid 20 international units/0.5 mL vaccine) injection: suspension, 0.5 mL syringe [Obsolete]) | is related to | 99011 (Tdap-IPV) |
| 10744051000116109 (Vivaxim (hepatitis A virus inactivated 160 ELISA units/mL + typhoid Vi polysaccharide 25 microgram/mL) vaccine injection: suspension, 1 mL syringe [Obsolete]) | is related to | 52101 (HepA-Typhoid) |
| 44318211000116104 (Hexaxim (diphtheria toxoid not less than 20 international units/0.5 mL + hepatitis B surface antigen recombinant 10 microgram/0.5 mL + Bordetella pertussis acellular antigens (pertussis toxoid 25 microgram/0.5 mL + filamentous haemagglutinin 25 microgram/0.5 mL) + poliovirus inactivated antigen (type 1 (Mahoney) 40 D antigen units/0.5 mL + type 2 (MEF-1) 8 D antigen units/0.5 mL + type 3 (Saukett) 32 D antigen units/0.5 mL) + tetanus toxoid not less than 40 international units/0.5 mL + Haemophilus influenzae type b polysaccharide conjugate 12 microgram/0.5 mL) vaccine injection: suspension, syringe [Obsolete]) | is related to | 210307 (DTaP-IPV-HepB/Hib) |
| 20069331000116107 (Verorab Inactivated Rabies Vaccine 2.5 international units (rabies virus (Wistar PM/WI 38-1503-3M) inactivated vaccine 2.5 international units) injection: powder for, vial) | is related to | 99009 (Rabies) |
| 47796751000116103 (Berirab P (rabies virus immunoglobulin, human 300 international units/2 mL) injection: solution, syringe) | is related to | 99010 (RIG) |
| 48262211000116108 (Influvac Tetra 2024 (A/Victoria/4897/2022 (H1N1) pdm09 - like virus 15 microgram/0.5 mL + A/Thailand/8/2022 (H3N2) - like virus 15 microgram/0.5 mL + B/Austria/1359417/2021 - like virus 15 microgram/0.5 mL + B/Phuket/3073/2013 - like virus 15 microgram/0.5 mL) influenza vaccine injection: suspension, syringe [Obsolete]) | is related to | 99006 (Influenza) |
| 48285331000116103 (Afluria Quad 2024 (A/Victoria/4897/2022 (H1N1) pdm09 - like virus 15 microgram/0.5 mL + A/Thailand/8/2022 (H3N2) - like virus 15 microgram/0.5 mL + B/Austria/1359417/2021 - like virus 15 microgram/0.5 mL + B/Phuket/3073/2013 - like virus 15 microgram/0.5 mL) influenza vaccine injection: suspension, syringe [Obsolete]) | is related to | 99006 (Influenza) |
| 48231281000116101 (Flucelvax Quad 2024 (A/Wisconsin/67/2022 (H1N1) pdm09 - like virus 15 microgram/0.5 mL + A/Massachusetts/18/2022 (H3N2) - like virus 15 microgram/0.5 mL + B/Austria/1359417/2021 - like virus 15 microgram/0.5 mL + B/Phuket/3073/2013 - like virus 15 microgram/0.5 mL) influenza vaccine injection: suspension, syringe [Obsolete]) | is related to | 99006 (Influenza) |
| 48294771000116100 (Fluad Quad 2024 (A/Victoria/4897/2022 (H1N1) pdm09 - like virus 15 microgram/0.5 mL + A/Thailand/8/2022 (H3N2) - like virus 15 microgram/0.5 mL + B/Austria/1359417/2021 - like virus 15 microgram/0.5 mL + B/Phuket/3073/2013 - like virus 15 microgram/0.5 mL) influenza vaccine injection: suspension, syringe [Obsolete]) | is related to | 99006 (Influenza) |
| 48322461000116106 (FluQuadri 2024 (A/Victoria/4897/2022 (H1N1) pdm09 - like virus 15 microgram/0.5 mL + A/Thailand/8/2022 (H3N2) - like virus 15 microgram/0.5 mL + B/Austria/1359417/2021 - like virus 15 microgram/0.5 mL + B/Phuket/3073/2013 - like virus 15 microgram/0.5 mL) influenza vaccine injection: suspension, syringe [Obsolete]) | is related to | 99006 (Influenza) |
| 48407111000116100 (Comirnaty JN.1 (bretovameran 48 microgram/0.48 mL) (30 microgram/0.3 mL administered dose) (light grey SDV) COVID-19 mRNA vaccine injection: suspension, vial) | is related to | 217 |
| 48407721000116108 (Comirnaty JN.1 (bretovameran 16 microgram/0.48 mL) (10 microgram/0.3 mL administered dose) (light blue SDV) COVID-19 mRNA vaccine injection: suspension, vial) | is related to | 218 |
| 48408951000116102 (Comirnaty JN.1 (bretovameran 15.8 microgram/0.48 mL) (3 microgram/0.3 mL administered dose) (yellow MDV) COVID-19 mRNA vaccine injection: concentrated, vial) | is related to | 219 |
| 48606481000116100 (Flucelvax Quad 2025 (A/Wisconsin/67/2022 (H1N1) pdm09 - like virus 15 microgram/0.5 mL + A/District of Columbia/27/2023 (H3N2) - like virus 15 microgram/0.5 mL + B/Austria/1359417/2021 - like virus 15 microgram/0.5 mL + B/Phuket/3073/2013 - like virus 15 microgram/0.5 mL) influenza vaccine injection: suspension, syringe) | is related to | 99006 (Influenza) |
| 48583461000116109 (Influvac Tetra 2025 (A/Victoria/4897/2022 (H1N1) pdm09 - like virus 15 microgram/0.5 mL + A/Croatia/10136RV/2023 (H3N2)-like virus 15 microgram/0.5 mL + B/Austria/1359417/2021 - like virus 15 microgram/0.5 mL + B/Phuket/3073/2013 - like virus 15 microgram/0.5 mL) influenza vaccine injection: suspension, syringe [obsolete]) | is related to | 99006 (Influenza) |
| 48606291000116104 (Fluad Quad 2025 (A/Victoria/4897/2022 (H1N1) pdm09 - like virus 15 microgram/0.5 mL + A/Croatia/10136RV/2023 (H3N2)-like virus 15 microgram/0.5 mL + B/Austria/1359417/2021 - like virus 15 microgram/0.5 mL + B/Phuket/3073/2013 - like virus 15 microgram/0.5 mL) influenza vaccine injection: suspension, syringe) | is related to | 99006 (Influenza) |
| 48611851000116100 (FluQuadri 2025 (A/Victoria/4897/2022 (H1N1) pdm09 - like virus 15 microgram/0.5 mL + A/Croatia/10136RV/2023 (H3N2)-like virus 15 microgram/0.5 mL + B/Austria/1359417/2021 - like virus 15 microgram/0.5 mL + B/Phuket/3073/2013 - like virus 15 microgram/0.5 mL) influenza vaccine injection: suspension, syringe) | is related to | 99006 (Influenza) |
| 48606101000116102 (Afluria Quad 2025 (A/Victoria/4897/2022 (H1N1) pdm09 - like virus 15 microgram/0.5 mL + A/Croatia/10136RV/2023 (H3N2)-like virus 15 microgram/0.5 mL + B/Austria/1359417/2021 - like virus 15 microgram/0.5 mL + B/Phuket/3073/2013 - like virus 15 microgram/0.5 mL) influenza vaccine injection: suspension, syringe) | is related to | 99006 (Influenza) |
| 45442391000116106 (Synagis (palivizumab 100 mg/mL) injection: solution, vial) | is related to | 93 |
| 48709091000116105 (Comirnaty LP.8.1 (mRNA encoding LP.8.1 15.8 microgram/0.48 mL) (3 microgram/0.3 mL administered dose) (yellow MDV) COVID-19 mRNA vaccine injection: concentrated, vial) | is related to | 219 |
| 48709061000116101 (Comirnaty LP.8.1 (mRNA encoding LP.8.1 16 microgram/0.48 mL) (10 microgram/0.3 mL administered dose) (light blue SDV) COVID-19 mRNA vaccine injection: suspension, vial) | is related to | 218 |
| 48709151000116103 (Comirnaty LP.8.1 (mRNA encoding LP.8.1 42 microgram/0.418 mL) (30 microgram/0.3 mL administered dose) (glass) COVID-19 mRNA vaccine injection: suspension, syringe) | is related to | 217 |
| 48833691000116109 (Flucelvax 2026 (A/Missouri/11/2025 (H1N1) pdm09 - like virus 15 microgram/0.5 mL + A/Sydney/1359/2024 (H3N2) - like virus 15 microgram/0.5 mL + B/Austria/1359417/2021 - like virus 15 microgram/0.5 mL) influenza vaccine injection: suspension, syringe) | is related to | 99006 (Influenza) |
| 48843351000116107 (Influvac Tetra 2026 (A/Missouri/11/2025 (H1N1) pdm09 - like virus 15 microgram/0.5 mL + A/Singapore/GP20238/2024 (H3N2) - like virus 15 microgram/0.5 mL + B/Austria/1359417/2021 - like virus 15 microgram/0.5 mL + B/Phuket/3073/2013 - like virus 15 microgram/0.5 mL) influenza vaccine injection: suspension, syringe) | is related to | 99006 (Influenza) |
| 48838141000116100 (Fluad 2026 (A/Missouri/11/2025 (H1N1) pdm09 - like virus 15 microgram/0.5 mL + A/Singapore/GP20238/2024 (H3N2) - like virus 15 microgram/0.5 mL + B/Austria/1359417/2021 - like virus 15 microgram/0.5 mL) influenza vaccine injection: suspension, syringe) | is related to | 99006 (Influenza) |
| 48864131000116105 (Fluzone 2026 (A/Missouri/11/2025 (H1N1) pdm09 - like virus 15 microgram/0.5 mL + A/Singapore/GP20238/2024 (H3N2) - like virus 15 microgram/0.5 mL + B/Austria/1359417/2021 - like virus 15 microgram/0.5 mL) influenza vaccine injection: suspension, syringe) | is related to | 99006 (Influenza) |